Identification of recurrence-related serum microRNAs in hepatocellular carcinoma following hepatectomy

References

• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136:E359-86; PMID:25220842; http://dx.doi.org/10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 2000; 191:381-8; PMID:11030243; http://dx.doi.org/10.1016/S1072-7515(00)00700-6
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-36; PMID:16250051; http://dx.doi.org/10.1002/hep.20933
   PubMed Web of Science ®Google Scholar
• Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 2007; 141:330-9; PMID:17349844; http://dx.doi.org/10.1016/j.surg.2006.06.028
   PubMed Web of Science ®Google Scholar
• Lubrano J, Huet E, Tsilividis B, Francois A, Goria O, Riachi G, Scotté M. Long-term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse. World J Surg 2008; 32:104-9; PMID:18026787; http://dx.doi.org/10.1007/s00268-007-9291-0
   PubMed Web of Science ®Google Scholar
• Franssen B, Jibara G, Tabrizian P, Schwartz ME, Roayaie S. Actual 10-year survival following hepatectomy for hepatocellular carcinoma. HPB (Oxford) 2014; 16:830-5; PMID:24372853; http://dx.doi.org/10.1111/hpb.12206
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; http://dx.doi.org/10.1016/j.cell.2009.01.002
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513-8; PMID:18663219; http://dx.doi.org/10.1073/pnas.0804549105
   PubMed Web of Science ®Google Scholar
• Nair VS, Maeda LS, Ioannidis JP. Clinical outcome prediction by microRNAs in human cancer: a systematic review. J Natl Cancer Inst 2012; 104:528-40; PMID:22395642; http://dx.doi.org/10.1093/jnci/djs027
   PubMed Web of Science ®Google Scholar
• Barry CT, D'Souza M, McCall M, Safadjou S, Ryan C, Kashyap R, Marroquin C, Orloff M, Almudevar A, Godfrey TE. Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation. Am J Transplant 2012; 12:428-37; PMID:22008552; http://dx.doi.org/10.1111/j.1600-6143.2011.03788.x
   PubMed Web of Science ®Google Scholar
• Liu M, Liu J, Wang L, Wu H, Zhou C, Zhu H, Xu N, Xie Y. Association of Serum MicroRNA Expression in Hepatocellular Carcinomas Treated with Transarterial Chemoembolization and Patient Survival. PLoS One 2014; 9:e109347; PMID:25275448; http://dx.doi.org/10.1371/journal.pone.0109347
   PubMed Web of Science ®Google Scholar
• Sato F, Hatano E, Kitamura K, Myomoto A, Fujiwara T, Takizawa S, Tsuchiya S, Tsujimoto G, Uemoto S, Shimizu K. MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria. PLoS One 2011; 6:e16435; PMID:21298008; http://dx.doi.org/10.1371/journal.pone.0016435
   PubMed Web of Science ®Google Scholar
• Utsunomiya T, Ishikawa D, Asanoma M, Yamada S, Iwahashi S, Kanamoto M, Arakawa Y, Ikemoto T, Morine Y, Imura S, et al. Specific miRNA expression profiles of non-tumor liver tissue predict a risk for recurrence of hepatocellular carcinoma. Hepatol Res 2014; 44:631-8; PMID:23682578; http://dx.doi.org/10.1111/hepr.12164
   PubMed Web of Science ®Google Scholar
• Zhu HT, Dong QZ, Sheng YY, Wei JW, Wang G, Zhou HJ, Ren N, Jia HL, Ye QH, Qin LX. MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection. PLoS One 2012; 7:e52393; PMID:23285022; http://dx.doi.org/10.1371/journal.pone.0052393
   PubMedGoogle Scholar
• Tomimaru Y, Eguchi H, Nagano H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Tomokuni A, Takemasa I, Umeshita K, et al. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol 2012; 56:167-75; PMID:21749846; http://dx.doi.org/10.1016/j.jhep.2011.04.026
   PubMed Web of Science ®Google Scholar
• Koberle V, Kronenberger B, Pleli T, Trojan J, Imelmann E, Peveling-Oberhag J, Welker MW, Elhendawy M, Zeuzem S, Piiper A, et al. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. Eur J Cancer 2013; 49:3442-9; PMID:23810247; http://dx.doi.org/10.1016/j.ejca.2013.06.002
   PubMed Web of Science ®Google Scholar
• Qi R, Weiland M, Gao XH, Zhou L, Mi QS. Identification of endogenous normalizers for serum microRNAs by microarray profiling: U6 small nuclear RNA is not a reliable normalizer. Hepatology 2012; 55:1640-2; author reply 2-3; PMID:22213067; http://dx.doi.org/10.1002/hep.25558
   PubMed Web of Science ®Google Scholar
• Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z. Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One 2009; 4:e8003; PMID:19946373; http://dx.doi.org/10.1371/journal.pone.0008003
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang Y, Yang T, Yuan S, Wang R, Pan Z, Yang Y, Huang G, Gu F, Jiang B, et al. Double-negative feedback loop between microRNA-422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis. Hepatology 2015; 61:561-73; PMID:25251503; http://dx.doi.org/10.1002/hep.27491
   PubMed Web of Science ®Google Scholar
• Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, Danforth D, Hastings ML, Duelli DM. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 2010; 5:e13515; PMID:20976003; http://dx.doi.org/10.1371/journal.pone.0013515
   PubMed Web of Science ®Google Scholar
• Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, Wei SH, Curley SA, Laurent A, Poon RT, et al. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg 2013; 17:66-77; discussion p; PMID:22948836; http://dx.doi.org/10.1007/s11605-012-2005-4
   PubMed Web of Science ®Google Scholar
• Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection. Cancer 2013; 119:126-35; PMID:22736338; http://dx.doi.org/10.1002/cncr.27697
   PubMed Web of Science ®Google Scholar
• Small EM, O'Rourke JR, Moresi V, Sutherland LB, McAnally J, Gerard RD, Richardson JA, Olson EN. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci U S A 2010; 107:4218-23; PMID:20142475; http://dx.doi.org/10.1073/pnas.1000300107
   PubMed Web of Science ®Google Scholar
• Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, et al. Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res 2011; 17:2657-67; PMID:21415212; http://dx.doi.org/10.1158/1078-0432.CCR-10-3152
   PubMed Web of Science ®Google Scholar
• Wang J, Tian X, Han R, Zhang X, Wang X, Shen H, Xue L, Liu Y, Yan X, Shen J, et al. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene 2014; 33:1181-9; PMID:23474761; http://dx.doi.org/10.1038/onc.2013.42
   PubMed Web of Science ®Google Scholar
• Zhang G, Liu Z, Cui G, Wang X, Yang Z. MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells. Tumour Biol 2014; 35(11):11137-45; PMID:25104088
   PubMed Web of Science ®Google Scholar
• Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. FEBS J 2015; 282:579-94; PMID:25475121; http://dx.doi.org/10.1111/febs.13167
   PubMed Web of Science ®Google Scholar
• Kim YJ, Hwang SH, Lee SY, Shin KK, Cho HH, Bae YC, Jung JS. miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose. Stem Cells Dev 2012; 21:1749-60; PMID:21988232; http://dx.doi.org/10.1089/scd.2011.0429
   PubMed Web of Science ®Google Scholar
• Petersen KF, Krssak M, Navarro V, Chandramouli V, Hundal R, Schumann WC, Landau BR, Shulman GI. Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis. Am J Physiol 1999; 276:E529-35; PMID:10070020
   PubMedGoogle Scholar
• Bezborodkina NN, Chestnova AY, Okovity SV, Kudryavtsev BN. Activity of glycogen synthase and glycogen phosphorylase in normal and cirrhotic rat liver during glycogen synthesis from glucose or fructose. Exp Toxicol Pathol 2014; 66:147-54; PMID:24373751; http://dx.doi.org/10.1016/j.etp.2013.12.001
   PubMed Web of Science ®Google Scholar
• Liang L, Wong CM, Ying Q, Fan DN, Huang S, Ding J, Yao J, Yan M, Li J, Yao M, et al. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology 2010; 52:1731-40; PMID:20827722; http://dx.doi.org/10.1002/hep.23904
   PubMed Web of Science ®Google Scholar
• Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, Stokes A, Francis T, Hughart N, Hubble L, et al. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol 2011; 55:1339-45; PMID:21703189; http://dx.doi.org/10.1016/j.jhep.2011.04.015
   PubMed Web of Science ®Google Scholar
• Kim JK, Noh JH, Jung KH, Eun JW, Bae HJ, Kim MG, Chang YG, Shen Q, Park WS, Lee JY, et al. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology 2013; 57:1055-67; PMID:23079745; http://dx.doi.org/10.1002/hep.26101
   PubMed Web of Science ®Google Scholar
• Li W, Xie L, He X, Li J, Tu K, Wei L, Wu J, Guo Y, Ma X, Zhang P, et al. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 2008; 123:1616-22; PMID:18649363; http://dx.doi.org/10.1002/ijc.23693
   PubMed Web of Science ®Google Scholar
• Wong CC, Wong CM, Tung EK, Au SL, Lee JM, Poon RT, Man K, Ng IO. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 2011; 140:322-31.; PMID:20951699; http://dx.doi.org/10.1053/j.gastro.2010.10.006
   PubMed Web of Science ®Google Scholar
• Fan Q, He M, Deng X, Wu WK, Zhao L, Tang J, Wen G, Sun X, Liu Y. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma. Cell Biochem Funct 2013; 31:319-24; PMID:23001723; http://dx.doi.org/10.1002/cbf.2902
   PubMed Web of Science ®Google Scholar
• Gu W, Li X, Wang J. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Oncol Rep 2014; 31:397-404; PMID:24190507
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar